Trial Profile
Post Marketing Surveillance in Japan on Long Term Drug Use of JARDIANCE Tablets in Patients With Type 2 Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Feb 2022
Price :
$35
*
At a glance
- Drugs Empagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Boehringer Ingelheim
- 23 Dec 2020 Status changed from active, no longer recruiting to completed.
- 04 Oct 2020 Planned primary completion date changed from 30 Sep 2020 to 23 Nov 2020.
- 04 Jun 2020 Planned primary completion date changed from 31 May 2020 to 30 Sep 2020.